Cargando…
Macrocyclic Peptidomimetic Plasmepsin X Inhibitors with Potent In Vitro and In Vivo Antimalarial Activity
[Image: see text] The Plasmodium falciparum aspartic protease plasmepsin X (PMX) is essential for the egress of invasive merozoite forms of the parasite. PMX has therefore emerged as a new potential antimalarial target. Building on peptidic amino alcohols originating from a phenotypic screening hit,...
Autores principales: | Kovada, Vadims, Withers-Martinez, Chrislaine, Bobrovs, Raitis, Ce̅rule, Hele̅na, Liepins, Edgars, Grinberga, Solveiga, Hackett, Fiona, Collins, Christine R., Kreicberga, Agrita, Jiménez-Díaz, María Belén, Angulo-Barturen, Iñigo, Rasina, Dace, Suna, Edgars, Jaudzems, Kristaps, Blackman, Michael J., Jirgensons, Aigars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424242/ https://www.ncbi.nlm.nih.gov/pubmed/37505188 http://dx.doi.org/10.1021/acs.jmedchem.3c00812 |
Ejemplares similares
-
Peptidomimetic plasmepsin inhibitors with potent anti-malarial activity and selectivity against cathepsin D
por: Zogota, Rimants, et al.
Publicado: (2019) -
3-(Adenosylthio)benzoic Acid Derivatives as SARS-CoV-2 Nsp14 Methyltransferase Inhibitors
por: Bobileva, Olga, et al.
Publicado: (2023) -
Potent SARS-CoV-2 mRNA Cap Methyltransferase
Inhibitors by Bioisosteric Replacement of Methionine in SAM Cosubstrate
por: Bobiļeva, Olga, et al.
Publicado: (2021) -
Discovery of SARS-CoV-2 Nsp14 and Nsp16 Methyltransferase Inhibitors by High-Throughput Virtual Screening
por: Bobrovs, Raitis, et al.
Publicado: (2021) -
Essentiality of Plasmodium falciparum plasmepsin V
por: Boonyalai, Nonlawat, et al.
Publicado: (2018)